View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Analysis
May 18, 2016

Pharma Technology Focus – Issue 47

In this issue: The breast cancer drug pipeline, getting biosimilars to market, the debate about animal research, olive leaf extract on trial, text mining in the biotech sector, outsourcing clinical trials in emerging markets and more.

By Susanne Hauner

Pharma Technology Focus

Pharma Technology Focus is free for the iPad. Download our app to read the latest issue and browse our back issues for free.

The breast cancer treatment pipeline shows exceptional levels of activity and innovation, with 1,050 drugs in active development across all stages. We find out what makes this such a lucrative and promising field and ask whether research in this area of oncology could provide a model for others.

We also hear from KeyPharma about the best strategies for getting biosimilars to market, find out about the difficulties of using animals in selecting drug candidates for human trials, get an insight into best practice for outsourcing clinical trials to emerging countries, and hear from GlobalData about why immunising children against influenza is gaining steam.

Plus, we find out about the therapeutic potential of olive leaf extract, find out how text mining can help to speed up R&D in the biotech sector, and get an insight into the challenges of setting up pharmaceutical distribution services.

Read the issue for free on your iPad through our app, or if you’re on a desktop computer you can also read it in our web viewer.

In this issue

Pharma’s Biggest Success Story?The breast cancer treatment pipeline is the largest in the pharma industry. Dominic Trewartha, managing analyst for GBI Research, explains why breast cancer is such a lucrative and promising field and how other indications can follow suit.Read the article.

Paving the WayThe opportunity to rein in healthcare spending on biotech products is evoking greater interest in biosimilars. ProductLife Group’s biotech expert Barbara Testa discusses the challenges in bringing biosimilars to market.Read the article.

Immunising Against InfluenzaGlobalData’s analyst for infectious diseases Achilleas Livieratos, PhD, explains why immunising children against seasonal influenza is gaining steam.Read the article.

Of Mice and MenAnimal research is a central pillar of drug development, but in medical terms, do the ends justify the means? Chris Lo hears both sides of the debate from Dr Jarrod Bailey of Cruelty Free International and Chris Magee of Understanding Animal Research.Read the article.

Olive Leaf Extract on Trial Olive leaf extract has been making a comeback as a natural remedy, with evidence to suggest an array of health benefits. Abi Millar finds out how far olive leaf extract testing has gone and whether there is any chance of seeing it reclassified as a bona-fide pharmaceutical.Read the article.

Information OverloadText mining – the use of advanced computational methods to sift through reams of textual data- could speed up the clinical research process. Elly Earls meets Professor Sophia Ananiadou, director of the National Centre for Text Mining at the Manchester Institute of Biotechnology, to find out how.Read the article.

New FrontiersThe pharma industry is increasingly looking to expand into emerging markets, and the outsourcing model is a common way of approaching local clinical research. Cameron Tew, executive director of research services at Best Practices, tells Chris Lo how to conduct effective trials in new markets.Read the article.

Saving Lives Leslie Morgan, CEO of medical supply company Durbin, has more experience of the pharmaceutical supply chain than most. Elly Earls finds out about his journey in the industry, the evolution of pharmaceutical distribution, and why every patient counts.Read the article.

Next issue preview

The UK’s research and development tax credit scheme has the potential to offset some of the cost of innovation for pharma companies operating in Britain, but understanding the ins and outs of this complex tax relief programme is no easy task. We find out more about the scheme and new legislation could complicate matters.

We also consider ways to unlock the potential for the pharma industry to help drive socio-economic transformations in Africa, look at a new treatment for prostate cancer and find out more about the benefits of treating chronic heroin addiction with hydromorphone.

Plus, we take a look at how scientists are finding ways to make pharmaceutical drugs more sustainable, and discover how eating blueberries could help to reduce the genetic and biochemical drivers behind depression.

Digital magazine FAQ

You can read Pharma Technology Focus for free on the iPad. Download our app from the App Store to read the latest issue and browse the back issues in our archive. Sign up for a free subscription in the app and never miss a new issue.

You can also continue to read the desktop version for free on our web viewer. (Browser compatibility: The web viewer works in the latest two version of Chrome, Firefox and Safari, as well as in Internet Explorer 9 and 10. Some features may not be compatible with older browser versions.)

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Pharmaceutical Technology